Adequacy Measurement for the 21st Century: Revisiting Kt/Vurea

Area of Science:

• Nephrology
• Clinical Quality Metrics
• Renal Replacement Therapy

Background:

• Medicare mandates quality assurance in dialysis care for end-stage kidney disease.
• The Centers for Medicare & Medicaid Services (CMS) uses clinical guidelines to set quality standards for dialysis facilities.
• CMS selected the minimal single pool Kt/V of urea (Kt/V) as a metric for dialysis dose adequacy.

Purpose of the Study:

• To review the evolution of Kt/V as a dialysis adequacy metric.
• To assess the limitations of Kt/V in ensuring adequate solute clearance.
• To recommend changes in quality metrics for dialysis care.

Main Methods:

• Narrative review of the literature on Kt/V and dialysis adequacy.
• Analysis of guideline-recommended Kt/V metrics and their basis in clinical trials.
• Consideration of recent hemodiafiltration trial results.

Main Results:

• Kt/V alone is insufficient to guarantee clearance of all uremic solutes in dialysis patients.
• Guideline-recommended Kt/V metrics may not be generalizable, especially for patients with residual kidney function.
• Factors beyond Kt/V in dialysis treatment can impact patient outcomes.

Conclusions:

• "Dialysis adequacy" should no longer be used synonymously with Kt/V.
• The emphasis on single-treatment Kt/V as a key quality metric should be reduced.
• Rethinking dialysis quality metrics is necessary to better reflect patient outcomes.